Chardan Capital Initiates Buy Rating on Hyperliquid Strategies with $8.15 Price Target
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 24 2025
0mins
Source: Benzinga
- Rating Initiation: Chardan Capital analyst James McIlree initiated coverage on Hyperliquid Strategies Inc. (NASDAQ:PURR) with a Buy rating and a price target of $8.15, indicating confidence in the company's future growth prospects.
- Market Performance: Hyperliquid Strategies shares closed at $3.32 on Tuesday, and the analyst's target price suggests a potential upside of 145%, which could attract investor interest and boost market confidence.
- Hyperion DeFi Rating: Similarly, Chardan Capital initiated coverage on Hyperion DeFi, Inc. (NASDAQ:HYPD) with a Buy rating and a price target of $7.75, reflecting a positive outlook on its market potential.
- Stock Price Potential: Hyperion DeFi shares closed at $3.75 on Tuesday, and the analyst's target price implies nearly a 106% upside, which may draw more investor interest and drive the stock price higher.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HYPD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HYPD
Wall Street analysts forecast HYPD stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.440
Low
4.00
Averages
5.88
High
7.75
Current: 3.440
Low
4.00
Averages
5.88
High
7.75
About HYPD
Hyperion DeFi, Inc. is engaged in building a long-term strategic treasury of Hyperliquid’s native token, HYPE. The Company is focused on providing simplified access to the Hyperliquid ecosystem. It is also developing its proprietary Optejet User Filled Device (UFD) that is designed to work with a variety of topical ophthalmic liquids, including artificial tears and lens rewetting products. The Optejet is useful in chronic front-of-the-eye diseases due to its ease of use, enhanced safety and tolerability, and potential for superior compliance versus standard eye drops. Together, these benefits may result in higher treatment compliance and better outcomes for patients and providers. It has launched its cryptocurrency treasury reserve, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid. Hyperliquid is a layer one blockchain (L1) written and optimized from first principles.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Guidance Increase: Hyperion DeFi Inc raised its full-year 2026 guidance by 20%, indicating strong business momentum that is likely to enhance investor confidence and potentially boost stock performance.
- Significant Profit Growth: The company reported a 119% increase in adjusted gross profit since Q3, showcasing effective execution of its DeFi strategy, which may attract more investor interest in its future performance.
- Surge in Trading Volume: HYPD's DeFi monetization vertical grew by 140% this quarter, driven by strategic partnerships and increased trading volumes, further solidifying its competitive position in the market.
- Successful Capital Raise: The company successfully raised $10 million in a public offering, strengthening its financial foundation for future growth, although the 33% decline in HYPE token price since Q3 could impact future financial performance.
See More
- Guidance Increase: Hyperion DeFi raised its 2026 adjusted gross profit guidance from $4 million to $6 million to a new range of $5 million to $7 million, anticipating cash flow breakeven by year-end, which reflects the company's confidence in future growth.
- DeFi Revenue Growth: The HyperCore DeFi monetization vertical grew by 140% this quarter, while yield enhancement strategies saw over 150% growth, indicating significant progress in the rapidly expanding decentralized finance market.
- Financial Performance Improvement: Q1 adjusted gross profit reached $960,000, a 17% sequential increase from the previous quarter, while net asset value rose from $44.2 million to $69.9 million, showcasing the company's ongoing financial health improvement.
- Ecosystem Reward Volatility: Management highlighted that ecosystem rewards remain variable, with expectations of quarter-over-quarter fluctuations due to the unpredictable timing of airdrops, which could impact future earnings forecasts.
See More
- Earnings Highlights: Hyperion DeFi reported a Q1 GAAP EPS of $0.26 with revenue of $240,000, a significant increase from $14,670 year-over-year, indicating strong growth momentum in the DeFi sector.
- Adjusted Gross Profit Guidance: The company raised its adjusted gross profit guidance for FY 2026 by approximately 20%, projecting adjusted gross profits between $4 million and $6 million, which represents a fivefold increase compared to 2025 actuals, reflecting optimism about future market conditions.
- Quarterly Guidance: Hyperion DeFi's latest guidance anticipates adjusted gross profits of $440,000 and $820,000 for Q3 and Q4 of FY 2025, respectively, showcasing the company's sustained profitability and growth potential in the upcoming quarters.
- Ecosystem Expansion: With the expansion of DeFi monetization and ecosystem partnerships, Hyperion DeFi's market outlook appears promising, likely driving further revenue and profit growth while solidifying its competitive position in the industry.
See More
- Successful Public Offering: Hyperion DeFi has closed its public offering of 2,777,778 shares at $3.60 each, raising approximately $10 million, which provides essential funding for the company's future growth initiatives.
- Underwriter's Option: The company granted the sole underwriter a 30-day option to purchase an additional 416,666 shares at the public offering price, which could further enhance the company's capital structure and flexibility.
- Clear Use of Proceeds: The net proceeds will fund the HYPE treasury strategy, including acquiring more HYPE tokens and working capital, indicating the company's proactive approach to future growth opportunities.
- Support from Strategic Investors: The financing was led by strategic investors like Arrington Capital and Blockchain.com, reflecting market confidence in Hyperion DeFi's infrastructure development in the cryptocurrency sector, potentially attracting more institutional capital into the ecosystem.
See More
- Earnings Call Announcement: Hyperion DeFi will hold its Q1 earnings conference call on May 14, 2026, at 8:00 a.m. ET, where detailed financial results will be released, aiding investors in assessing the company's performance and future outlook.
- Blockchain Technology Advantage: The Hyperliquid platform supports high-frequency transparent trading with 70-millisecond block times, offering fully on-chain perpetual futures and spot order books, enhancing trading efficiency and attracting more user participation.
- HYPE Token Performance: As of April 2026, approximately 44 million HYPE tokens have been autonomously purchased and sequestered by the blockchain, indicating strong trading fee generation capabilities that could provide the company with a continuous revenue stream.
- New Product Development: Hyperion DeFi is developing the Optejet User Filled Device, designed to enhance the usability of ophthalmic liquids and improve patient compliance, which may significantly impact the treatment of chronic front-of-the-eye diseases.
See More
- Management Conference Schedule: Hyperion DeFi will participate in the Digital Asset Yield Summit in Miami on May 4, 2026, followed by the Consensus event from May 4-7, showcasing its leadership in the DeFi space and likely attracting more investor interest.
- Global Event Agenda: The company will also attend Chardan's Crypto Salon in New York on May 27, Proof of Talk in Paris on June 2-3, and ETHConf in New York on June 8-10, highlighting its influence in the global blockchain ecosystem.
- Hyperliquid Day: On June 22, Hyperion DeFi will host Hyperliquid Day in Amsterdam, further promoting the use of its native token HYPE, which is expected to enhance user awareness and engagement within the Hyperliquid ecosystem.
- Innovative Product Development: The company is developing the Optejet User Filled Device aimed at improving treatment compliance for patients with eye diseases, which is anticipated to generate new revenue streams while enhancing patient outcomes.
See More








